These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7800343)

  • 1. Hyperthermia enhances the cytotoxicity against hypoxic cells of RP-170, a new 2-nitroimidazole nucleoside hypoxic cell sensitizer.
    Emi Y; Maehara Y; Kusumoto T; Baba H; Sakaguchi M; Sugimachi K
    Oncology; 1995; 52(1):55-9. PubMed ID: 7800343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hyperthermia on the activity of 1-[(4'-hydroxy-2'-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells.
    Kusumoto T; Maehara Y; Emi Y; Sakaguchi Y; Baba H; Sakaguchi M; Sugimachi K
    Cancer Chemother Pharmacol; 1993; 31(6):455-8. PubMed ID: 8453684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
    Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M
    Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
    Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
    Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC; Rupp WD; Rockwell S
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].
    Murayama C; Mori T
    Gan No Rinsho; 1990 Oct; 36(13):2249-54. PubMed ID: 2147449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia.
    Sutherland R; Macfarlane W
    Br J Cancer Suppl; 1978 Jun; 3():168-72. PubMed ID: 277220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
    Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypoxia on the cytotoxicity of misonidazole in HELA S3 cells in vitro.
    Ohizumi Y; Shibata C; Mori T
    Gan; 1980 Jun; 71(3):319-24. PubMed ID: 7418978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
    Twentyman PR
    Cancer Clin Trials; 1980; 3(3):253-6. PubMed ID: 7438322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C; Mori T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
    Shibamoto Y; Ono K; Takahashi M; Kano E; Hori H; Shibata T; Inayama S; Abe M
    Jpn J Cancer Res; 1986 Oct; 77(10):1027-33. PubMed ID: 3096918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The radiosensitizing effects of hypoxic cell sensitizer on SCCVII tumors in mice evaluated by highly accurate colony formation assay assisted by microcomputer.
    Ono K; Akuta K; Masunaga S; Kinashi Y; Suzuki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1066-70. PubMed ID: 9014470
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
    Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
    Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiosensitizer: hypoxic cell radiosensitizer].
    Mori T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between misonidazole and hyperthermia in EMT6 spheroids.
    Morgan JE; Bleehen NM
    Br J Cancer; 1981 Dec; 44(6):810-8. PubMed ID: 7326192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
    Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
    Fitzpatrick DA; Heindel ND; Egolf RA; Walton H
    Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.